一个模块化聚合物平台,用于癌症免疫治疗中高效的mRNA输送
Guanyou Lin1, Jianxi Huang1, Xinqi Li1
1Department of Materials Science and Engineering, University of Washington, Seattle, Washington 98195, USA. mzhang@uw.edu.
Nanoscale horizons
|August 7, 2025
概括
一种新的聚合物纳米平台,PFHA-PEI-mRNA-HP,增强了用于癌症基因治疗的信使RNA (mRNA) 传递. 与脂质纳米颗粒 (LNP) 相比,该平台显示出更高的效率和稳定性,在临床前模型中显著抑制瘤生长.
科学领域:
- 生物技术和纳米医学
- 基因治疗输送系统的基因疗法
背景情况:
- 由于mRNA的不稳定性,用于癌症和病毒感染的信使RNA (mRNA) 疗法需要有效的传递系统.
- 目前的脂质纳米颗粒 (LNP) 在安全性,储存和成本方面面临限制,这推动了对替代平台的需求.
- 聚合物输送系统提供结构多功能性和高转化效率,为LNP提供了有前途的替代方案.
研究的目的:
- 开发和评估一种新的聚合mRNA输送纳米平台,PFHA-PEI-mRNA-HP,以提高治疗效果.
- 研究聚乙烯胺 (PEI) 的同时化和化对mRNA复合体性能的影响.
- 评估PFHA-PEI-mRNA-HP在癌症基因治疗中的体外和体内疗效.
主要方法:
- 基于低分子量聚乙烯胺 (PEI) 的mRNA复合物的同时化和化,以产生PFHA-PEI-mRNA-HP.
- 评估纳米平台的物理化学性质,细胞吸收,内体体逃逸和生物相容性.
- 在多个癌症细胞系中进行体外传染效率评估,并与Lipofectamine 2000进行比较.
- 在体内研究使用三阴性乳腺癌小鼠模型,与IL12 mRNA输送结合抗PD-L1治疗.
主要成果:
- 在各种癌细胞类型中,PFHA-PEI-mRNA-HP表现出超高的传染效率 (>90%),超过了Lipofectamine 2000.
- 与Lipofectamine 2000相比,纳米平台在存储在0°C以上的15天期间表现出显著改善的稳定性.
- 在体内通过PFHA-PEI-mRNA-HP给予IL12mRNA,与抗PD-L1结合,有效地抑制了瘤生长,没有毒性.
结论:
- PFHA-PEI-mRNA-HP代表了一个高效和稳定的聚合物纳米平台,用于mRNA输送.
- 对PEI骨干的修改增强了mRNA复合体的性能,从而导致更好的转染和治疗结果.
- 这种纳米平台具有很大的潜力,可以作为一种可靠的工具来推进基于mRNA的癌症基因疗法.
相关概念视频
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Vaccines
510
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
510


